Skip to main content

Advertisement

Log in

Application of the Glucose Hydrogen Breath Test for the Detection of Bacterial Overgrowth in Patients with Cystic Fibrosis––A Reliable Method?

  • Original Article
  • Published:
Digestive Diseases and Sciences Aims and scope Submit manuscript

Abstract

Patients with cystic fibrosis (CF) have recently been deemed highly susceptible for bacterial intestinal overgrowth (BIO). We aimed to define the prevalence of BIO in children with CF by applying the H2-glucose breath test. Forty children with CF and ten healthy children received 1 g/kg D-glucose orally. Breath samples for H2 content (ppm) were collected for 3 h. BIO was suspected if the breath hydrogen content increased by more than 20 ppm or if baseline concentrations topped 20 ppm. In 27 of 40 CF children (68%), breath hydrogen content exceeded 20 ppm. Whereas the breath hydrogen exhalation persisted above 20 ppm in almost all these children throughout the sampling period, none of the remaining children increased above this threshold. The high rate of CF children with elevated fasting hydrogen breath concentrations indicates that this phenomenon is less a sign of BIO rather than a consequence of global malabsorption and intestinal dysmotility.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3

Similar content being viewed by others

References

  1. Donaldson RM Jr. Small bowel bacterial overgrowth. Adv Intern Med. 1970;16:191–212.

    PubMed  Google Scholar 

  2. Barbara G, Stanghellini V, Brandi G, et al. Interactions between commensal bacteria and gut sensorimotor function in health and disease. Am J Gastroenterol. 2005;100:2560–2568. doi:10.1111/j.1572-0241.2005.00230.x.

    Article  PubMed  CAS  Google Scholar 

  3. Quigley EM, Quera R. Small intestinal bacterial overgrowth: roles of antibiotics, prebiotics and probiotics. Gastroenterology. 2006;130:S78–S90. doi:10.1053/j.gastro.2005.11.046.

    Article  PubMed  CAS  Google Scholar 

  4. Husebye E. The pathogenesis of gastrointestinal bacterial overgrowth. Chemotherapy. 2005;51(Suppl 1):1–22. doi:10.1159/000081988.

    Article  PubMed  CAS  Google Scholar 

  5. Gunnarsdottir SA, Sadik R, Shev S, et al. Small intestinal motility disturbances and bacterial overgrowth in patients with liver cirrhosis and portal hypertension. Am J Gastroenterol. 2003;98:1362–1370. doi:10.1111/j.1572-0241.2003.07475.x.

    Article  PubMed  Google Scholar 

  6. Lin HC. Small intestinal bacterial overgrowth. A framework for understanding irritable bowel syndrome. JAMA. 2004;292:852–858. doi:10.1001/jama.292.7.852.

    Article  PubMed  CAS  Google Scholar 

  7. King CE, Toskes PP. Small intestine bacterial overgrowth. Gastroenterology. 1979;76:1035–1055.

    PubMed  CAS  Google Scholar 

  8. Banwell JG, Kistler LA, Giannella RA, Weber FL, Lieber A, Powell DE. Small intestinal bacterial overgrowth syndrome. Gastroenterology. 1981;80:834–845.

    Google Scholar 

  9. Schjonsby H, Hofstad T. The uptake of vitamin B12 by the sediment of jejunal contents in patients with blind loop syndrome. Scand J Gastroenterol. 1975;10:305–309.

    PubMed  CAS  Google Scholar 

  10. Steffen EK, Berg RD, Deitch EA. Comparison of translocation rates of various indigenous bacteria from the gastrointestinal tract to the mesenteric lymph node. J Infect Dis. 1988;157:1023–1028.

    Google Scholar 

  11. Riordan SM, McIver CJ, Wakefield D, Thomas MC, Dunscombe VM, Bolin TD. Serum immunoglobulin and soluble IL-2 receptor levels in small intestinal bacterial overgrowth with indigenous gut flora. Dig Dis Sci. 1999;44:939–944. doi:10.1023/A:1026652412554.

    Article  PubMed  CAS  Google Scholar 

  12. Bjorneklett A, Fausa O, Midtvedt T. Small-bowel bacterial overgrowth in the postgastrectomy syndrome. Scand J Gastroenterol. 1983;18:277–287.

    Article  PubMed  CAS  Google Scholar 

  13. Walters B, Vanner SJ. Detection of bacterial overgrowth in IBS using the lactulose H2 breath test: comparison with 14C-D-xylose and healthy controls. Am J Gastroenterol. 2005;100:1566–1570. doi:10.1111/j.1572-0241.2005.40795.x.

    Article  PubMed  CAS  Google Scholar 

  14. Pimentel M, Chow EJ, Lin HC. Eradication of small intestinal bacterial overgrowth reduces symptomas of irritable bowel syndrome. Am J Gastroenterol. 2000;95:3503–3506. doi:10.1111/j.1572-0241.2000.03368.x.

    Article  PubMed  CAS  Google Scholar 

  15. Lewindon PJ, Robb TA, Moore DJ, Davidson GP, Martin AJ. Bowel dysfunction in cystic fibrosis: importance of breath testing. J Paediatr Child Health. 1998;34:79–82. doi:10.1046/j.1440-1754.1998.00159.x.

    Article  PubMed  CAS  Google Scholar 

  16. Fridge JL, Conrad C, Gerson L, Castillo RO, Cox K. Risk factors for small bowel bacterial overgrowth in cystic fibrosis. J Pediatr Gastroenterol Nutr. 2007;44:212–218. doi:10.1097/MPG.0b013e31802c0ceb.

    Article  PubMed  Google Scholar 

  17. Norkina O, Burnett TG, de Lisle RC. Bacterial overgrowth in the cystic fibrosis transmembrane conductance regulator null mouse small intestine. Infect Immun. 2004;72:6040–6049. doi:10.1128/IAI.72.10.6040-6049.2004.

    Article  PubMed  CAS  Google Scholar 

  18. Kerem E, Conway S, Elborn S, Heijerman H. Consensus committee: standards of care for patients with cystic fibrosis: a European consensus. J Cyst Fibros. 2005;4:7–26. doi:10.1016/j.jcf.2004.12.002.

    Article  PubMed  Google Scholar 

  19. Kerlin P, Wong L. Breath hydrogen testing in bacterial overgrowth of the small intestine. Gastroenterology. 1988;95:982–988.

    PubMed  CAS  Google Scholar 

  20. King CE, Toskes PP. Comparison of the 1 g [14C]xylose, 10 g lactulose- H2, and 80 g glucose-H2 breath tests in patients with small intestine bacterial overgrowth. Gastroenterology. 1986;91:1447–1451.

    PubMed  CAS  Google Scholar 

  21. King CE, Toskes PP. Breath tests in the diagnosis of small intestine bacterial overgrowth. Crit Rev Clin Lab Sci. 1984;21:269–281.

    PubMed  CAS  Google Scholar 

  22. Corazza G, Sorge M, Strocchi A, Gasbarrini G. Glucose-H2 breath test for small intestine bacterial overgrowth. Gastroenterology. 1990;98:253–254.

    PubMed  CAS  Google Scholar 

  23. Keller J, Franke A, Storr M, et al. Clinically relevant breath tests in gastroenterological diagnostics-recommendations of the German Society for Neurogastroenterology and Motility as well as the German Society for Digestive and Metabolic Diseases. Z Gastroenterol. 2005;43:1071–1090. doi:10.1055/s-2005-858479.

    Article  PubMed  CAS  Google Scholar 

  24. Norkina O, Kaur S, Ziemer D, De Lisle RC. Inflammation of the cystic fibrosis mouse small intestine. Am J Physiol Gastrointest Liver Physiol. 2004;286:G1032–G1041. doi:10.1152/ajpgi.00473.2003.

    Article  PubMed  CAS  Google Scholar 

  25. De Lisle RC, Roach EA, Norkina O. Eradication of small intestinal bacterial overgrowth in the cystic fibrosis mouse reduces mucus accumulation. J Pediatr Gastroenterol Nutr. 2006;42:46–52. doi:10.1097/01.mpg.0000189322.34582.3e.

    Article  PubMed  Google Scholar 

  26. Romagnuolo J, Schiller D, Bailey RJ. Using breath tests wisely in a gastroenterology practice: an evidence-based review of indications and pitfalls in interpretation. Am J Gastroenterol. 2002;97:1113–1126. doi:10.1111/j.1572-0241.2002.05664.x.

    Article  PubMed  Google Scholar 

  27. Bali A, Stableforth DE, Asquith P. Prolonged small-intestinal transit time in cystic fibrosis. Br Med J (Clin Res Ed). 1983;287:1011–1013.

    Article  CAS  Google Scholar 

  28. Gregory PC. Gastrointestinal pH, motility/transit and permeability in cystic fibrosis. J Pediatr Gastroenterol Nutr. 1996;23:513–523. doi:10.1097/00005176-199612000-00001.

    Article  PubMed  CAS  Google Scholar 

  29. Escobar H, Perdomo M, Vasconez F, Camarero C, del Olmo MT, Suarez L. Intestinal permeability to 51Cr-EDTA and orocecal transit time in cystic fibrosis. J Pediatr Gastroenterol Nutr. 1992;14:204–207. doi:10.1097/00005176-199202000-00015.

    Article  PubMed  CAS  Google Scholar 

  30. Dalzell AM, Freestone NS, Billington D, Heaf DP. Small intestinal permeability and orocaecal transit time in cystic fibrosis. Arch Dis Child. 1990;65:585–588.

    Article  PubMed  CAS  Google Scholar 

Download references

Acknowledgment

This study was performed without funding from third parties. The authors do not have any disclosures to declare.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Arne R. J. Schneider.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Schneider, A.R.J., Klueber, S., Posselt, HG. et al. Application of the Glucose Hydrogen Breath Test for the Detection of Bacterial Overgrowth in Patients with Cystic Fibrosis––A Reliable Method?. Dig Dis Sci 54, 1730–1735 (2009). https://doi.org/10.1007/s10620-008-0559-5

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10620-008-0559-5

Keywords

Navigation